Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-04-12
2005-04-12
Desai, Rita (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S347000
Reexamination Certificate
active
06878730
ABSTRACT:
The invention features quaternary ammonium compounds of formula I, described herein, and their use in treating asthma, chronic obstructive pulmonary disorder, allergic rhinitis, and infectious rhinitis.
REFERENCES:
patent: 3505337 (1970-04-01), Zeile et al.
patent: 5036098 (1991-07-01), Kimura et al.
patent: 5948792 (1999-09-01), Tsuchiya et al.
patent: 6040449 (2000-03-01), Tsuchiya et al.
patent: 6130232 (2000-10-01), Mase et al.
patent: 6469172 (2002-10-01), Maligres et al.
patent: 20010051727 (2001-12-01), Maligres et al.
patent: 0106643 (1974-06-01), None
Int. J. Pharm, 33, 201-217, 1986.
Benson Gregg C.
Desai Rita
Pharmacia & UpJohn
Richardson Peter C.
Ronau Robert T.
LandOfFree
Quaternary ammonium compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quaternary ammonium compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quaternary ammonium compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3427841